Active Pharmaceutical Ingredients
Cannabinoid API's for licensed pharmaceutical formulation.
Cilo Cybin's API portfolio is built around controlled cannabinoid refinement, GMP traceability, and formulation-ready inputs for licensed partners.
API portfolio
Select the right cannabinoid API for regulated formulation programs.
Cilo Cybin's API portfolio is designed for buyers who need more than a cannabinoid commodity. The value sits in GMP manufacturing discipline, controlled refinement, analytical release, batch traceability, and documentation that can stand up to partner and regulatory review.
Use this catalogue to compare selected THC, CBD, CBG, CBN, CBC, THCV, CBT, and CBD-V inputs by product family, physical format, potency target, and intended manufacturing use across oils, capsules, edibles, topicals, compounding, and partner-defined product systems.
THC Products
THC crude, THC distillate, and refined THC inputs for controlled licensed product development.
Refined cannabinoid
Refined THC
98%+ THC specification target; highly refined clear to pale amber oil.
ProductFamilyFormTechnical data
THC CrudeCrude oilDark amber crude oil70%+ THC with minor cannabinoids; High-THC controlled API input
THC DistillateDistillateClear to amber refined oil88-92% THC with 3-4% CBG and 1-2% CBN; High-THC controlled API input
Refined THCRefined cannabinoidHighly refined clear to pale amber oil98%+ THC specification target; High-THC controlled API input
CBD Products
CBD isolate, CBD CRD, CBD crude, CBD distillate, and CBD-V inputs.
Crystal resistant distillate
CBD CRD
43-58% CBD with 15%+ minor cannabinoids; free-flowing amber oil.
Rare cannabinoid isolate
CBD-V
≥98% CBDV specification target; off-white to yellow crystalline powder.
ProductFamilyFormTechnical data
CBD CRDCrystal resistant distillateFree-flowing amber oil43-58% CBD with 15%+ minor cannabinoids; Low-THC compliant specification target
CBD IsolateIsolateOff-white crystalline powder≥99% CBD specification target; ≤0.01% THC specification target
CBD Crude 70%+Crude oilDark amber cannabinoid crude oil70%+ CBD-rich crude cannabinoid input; Controlled THC specification target
CBD Distillate 85%DistillateGolden amber refined oil85% CBD specification target; Controlled THC specification target
CBD-VRare cannabinoid isolateOff-white to yellow crystalline powder≥98% CBDV specification target; ≤0.01% THC specification target
Minor Cannabinoids
CBN, CBG, CBC, THCV, and CBT inputs for differentiated formulation programs.
Crystal resistant distillate
CBG CRD
20-40% CBG with 17%+ minor cannabinoids; low-viscosity golden oil.
Rare cannabinoid oil
CBC
95-99% CBC specification target; yellow-orange non-crystallizing thick oil.
Rare cannabinoid resin
THCV
≥95% THCV specification target; hard deep yellow to purple resin when exposed to oxygen.
ProductFamilyFormTechnical data
CBG CRDCrystal resistant distillateLow-viscosity golden oil20-40% CBG with 17%+ minor cannabinoids; ≤0.3% THC specification target
CBG IsolateIsolateFine white crystalline powder98%+ CBG specification target; ≤0.01% THC specification target
CBTBotanical distillateLow-viscosity amber oilCBT-rich botanical profile; Controlled specification target
CBCRare cannabinoid oilYellow-orange non-crystallizing thick oil95-99% CBC specification target; ≤0.05% THC specification target
THCVRare cannabinoid resinHard deep yellow to purple resin when exposed to oxygen≥95% THCV specification target; ≤0.05% THC specification target
Portfolio comparison
Quick technical scan of the active API range.
ProductFamilyFormPotency guide
THCVRare cannabinoid resinHard deep yellow to purple resin when exposed to oxygen≥95% THCV specification target
API enquiry
Discuss cannabinoid API requirements, potency targets, or product-fit questions.
Share the intended formulation route, potency range, and documentation needs so Cilo Cybin can recommend the correct cannabinoid API pathway.